These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

427 related articles for article (PubMed ID: 24018414)

  • 1. Mechanisms of vascular calcification in CKD-evidence for premature ageing?
    Shanahan CM
    Nat Rev Nephrol; 2013 Nov; 9(11):661-70. PubMed ID: 24018414
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Arterial "inflammaging" drives vascular calcification in children on dialysis.
    Sanchis P; Ho CY; Liu Y; Beltran LE; Ahmad S; Jacob AP; Furmanik M; Laycock J; Long DA; Shroff R; Shanahan CM
    Kidney Int; 2019 Apr; 95(4):958-972. PubMed ID: 30827513
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vascular Calcification: An Important Understanding in Nephrology.
    Zununi Vahed S; Mostafavi S; Hosseiniyan Khatibi SM; Shoja MM; Ardalan M
    Vasc Health Risk Manag; 2020; 16():167-180. PubMed ID: 32494148
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Early vascular ageing in chronic kidney disease: impact of inflammation, vitamin K, senescence and genomic damage.
    Dai L; Schurgers LJ; Shiels PG; Stenvinkel P
    Nephrol Dial Transplant; 2020 Mar; 35(Suppl 2):ii31-ii37. PubMed ID: 32162665
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of Uremic Toxins in Early Vascular Ageing and Calcification.
    Kyriakidis NC; Cobo G; Dai L; Lindholm B; Stenvinkel P
    Toxins (Basel); 2021 Jan; 13(1):. PubMed ID: 33401534
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prelamin A accelerates vascular calcification via activation of the DNA damage response and senescence-associated secretory phenotype in vascular smooth muscle cells.
    Liu Y; Drozdov I; Shroff R; Beltran LE; Shanahan CM
    Circ Res; 2013 May; 112(10):e99-109. PubMed ID: 23564641
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chronic kidney disease and premature ageing.
    Kooman JP; Kotanko P; Schols AM; Shiels PG; Stenvinkel P
    Nat Rev Nephrol; 2014 Dec; 10(12):732-42. PubMed ID: 25287433
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vascular pathologies in chronic kidney disease: pathophysiological mechanisms and novel therapeutic approaches.
    Düsing P; Zietzer A; Goody PR; Hosen MR; Kurts C; Nickenig G; Jansen F
    J Mol Med (Berl); 2021 Mar; 99(3):335-348. PubMed ID: 33481059
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardiovascular Calcification Heterogeneity in Chronic Kidney Disease.
    Hutcheson JD; Goettsch C
    Circ Res; 2023 Apr; 132(8):993-1012. PubMed ID: 37053279
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inflammation and Premature Ageing in Chronic Kidney Disease.
    Ebert T; Pawelzik SC; Witasp A; Arefin S; Hobson S; Kublickiene K; Shiels PG; Bäck M; Stenvinkel P
    Toxins (Basel); 2020 Apr; 12(4):. PubMed ID: 32260373
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phosphate is a vascular toxin.
    Shroff R
    Pediatr Nephrol; 2013 Apr; 28(4):583-93. PubMed ID: 23161206
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endothelin type A receptor blockade reduces vascular calcification and inflammation in rats with chronic kidney disease.
    Larivière R; Gauthier-Bastien A; Ung RV; St-Hilaire J; Mac-Way F; Richard DE; Agharazii M
    J Hypertens; 2017 Feb; 35(2):376-384. PubMed ID: 28005706
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Senescent Cells in Early Vascular Ageing and Bone Disease of Chronic Kidney Disease-A Novel Target for Treatment.
    Hobson S; Arefin S; Kublickiene K; Shiels PG; Stenvinkel P
    Toxins (Basel); 2019 Feb; 11(2):. PubMed ID: 30717151
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Smooth Muscle-Selective Nuclear Factor-κB Inhibition Reduces Phosphate-Induced Arterial Medial Calcification in Mice With Chronic Kidney Disease.
    Yoshida T; Yamashita M; Horimai C; Hayashi M
    J Am Heart Assoc; 2017 Nov; 6(11):. PubMed ID: 29146611
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vascular calcification in skin and subcutaneous tissue in patients with chronic and end-stage kidney disease.
    Ruderman I; Hewitson TD; Smith ER; Holt SG; Wigg B; Toussaint ND
    BMC Nephrol; 2020 Jul; 21(1):279. PubMed ID: 32677907
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Arterial Stiffness in Chronic Kidney Disease and End-Stage Renal Disease.
    London GM
    Blood Purif; 2018; 45(1-3):154-158. PubMed ID: 29478047
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hypoxia-inducible factor-1 plays a role in phosphate-induced vascular smooth muscle cell calcification.
    Mokas S; Larivière R; Lamalice L; Gobeil S; Cornfield DN; Agharazii M; Richard DE
    Kidney Int; 2016 Sep; 90(3):598-609. PubMed ID: 27470678
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A current understanding of vascular calcification in CKD.
    Paloian NJ; Giachelli CM
    Am J Physiol Renal Physiol; 2014 Oct; 307(8):F891-900. PubMed ID: 25143458
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The CDK9-cyclin T1 complex mediates saturated fatty acid-induced vascular calcification by inducing expression of the transcription factor CHOP.
    Shiozaki Y; Okamura K; Kohno S; Keenan AL; Williams K; Zhao X; Chick WS; Miyazaki-Anzai S; Miyazaki M
    J Biol Chem; 2018 Nov; 293(44):17008-17020. PubMed ID: 30209133
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Contribution of Gut Microbiota-Derived Uremic Toxins to the Cardiovascular System Mineralization.
    Filipska I; Winiarska A; Knysak M; Stompór T
    Toxins (Basel); 2021 Apr; 13(4):. PubMed ID: 33920096
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.